`
`PATENT
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Confirmation No. 5769
`
`Group Art Unit: 1656
`
`Examiner: Ciara McKnight
`
`) ) ) )
`
`) )
`
`)
`
`In re Application of Ge Wei et al.
`
`U.S. Application No. 18/068,418
`
`Filing Date: 12/19/2022
`
`For: PH20 Polypeptide Variants, Formulations
`and Uses Thereof
`
`AMENDMENT UNDER 37 C.F.R. § 1.111
`
`In response to the Non-Final Office Action dated 05/01/2024, having a three-month
`
`shortened statutory period for response set to expire 08/01/2024, Applicant requests entry of the
`
`following amendments and remarks in the above patent application. To the extent necessary, a
`
`petition for an extension of time under 37 C.F.R. § 1.136 is hereby made. Please charge any shortage
`
`in fees due in connection with the filing of this paper, including extension of time fees, to Deposit
`
`Account 50-0310 and please credit any excess fees to such deposit account.
`
`Listing of the Claims begins on page 2.
`
`Remarksbegin on page 6.
`
`Conclusion is on page 7.
`
`